Mumbai, November 27, 2025 – In a dramatic turnaround session on Tuesday, November 26, the Indian markets witnessed one of the fiercest rallies in beaten-down stocks this month. More than 20 stocks surged between 10% and 20%, with several locking at upper circuits amid frenzied buying from retail and high-net-worth traders.
Pharma and agrochem names stole the show, while penny and small-cap favourites that had been hammered for months suddenly came alive with massive volume.
Top 20 Gainers on NSE – Tuesday, November 26, 2025
- SVP Global ↑ 20.00% → ₹5.70 (Upper circuit)
- Best Agrolife ↑ 19.99% → ₹362 (Upper circuit)
- Indo US ↑ 19.99% → ₹132.58 (Upper circuit)
- Globe Civil ↑ 17.99% → ₹74.10
- SMS Pharmaceuticals ↑ 17.68% → ₹321.90
- Vikas Ecotech ↑ 16.33% → ₹1.71
- Bigbloc Construction ↑ 13.83% → ₹65.28
- Laxmi Dental (LPDC) ↑ 13.69% → ₹8.97
- Rossari Biotech ↑ 12.43% → ₹779
- Responsive Industries ↑ 12.07% → ₹212.55
- Magnum Ventures ↑ 11.16% → ₹24.50
- Axita Cotton ↑ 11.04% → ₹9.15
- Natco Pharma ↑ 10.80% → ₹924.05 (₹1,772 crore traded!)
- Vikas Lifecare ↑ 10.80% → ₹1.95
- Ajooni Biotech ↑ 10.30% → ₹4.82
- Marine Electricals (MGEL) ↑ 10.11% → ₹15.68
- Paras Petrofils ↑ 10.10% → ₹2.18
- Ruchi Infrastructure ↑ 9.98% → ₹6.83
- Sadbhav Engineering ↑ 9.92% → ₹11.08
- Fino Payments Bank ↑ 9.73% → ₹292
Tuesday’s standout was Natco Pharma, which clocked a staggering ₹1,772 crore in turnover — one of the highest single-day figures for any mid-cap stock this year — as investors piled in ahead of expected strong quarterly numbers and new launches.
SMS Pharma saw volumes explode 30–40 times the average, while Best Agrolife and Indo US remained frozen at 20% upper circuits throughout the day.
Traders say the trigger was a deadly cocktail of extreme oversold conditions, short covering, and fresh bottom-fishing by operators in pharma, agrochem, and construction ancillary names that had fallen 60–90% from their 2021–2024 peaks.
Such violent single-day bounces often mark sentiment turning points in individual stocks and sectors. With broader indices still range-bound, rotational money is clearly chasing these high-beta, high-volume breakout candidates.
